Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Smartheart is a Swiss long-term EKG service for medical professionals and institutions, not a direct-to-patient product. It bundles wireless waterproof ECG sensors, the SmartheartOS platform, and a service team to help clinics, hospitals, and research institutions conduct long-term rhythm monitoring. Its core value is reducing the burden of purchasing devices, maintenance, logistics, and report pre-processing, while leaving final medical validation and diagnosis in the hands of physicians.
The service workflow is fairly complete: medical institutions order EKG Kits on demand through SmartheartOS; sensors can be fitted in the clinic or shipped to the patient’s home for self-use; after monitoring, the patient mails the sensor back; once the sensor arrives, a detailed EKG report is available within 48 hours. Reports are analyzed by AI and pre-validated by certified cardiovascular technicians, and can include the clinic’s logo and a pre-drafted physician letter. The sensors are positioned as wireless, waterproof, and comfortable for everyday wear, making them suitable for sleep, exercise, showering, and similar scenarios. The website states that use can extend up to 30 days, while the service page also lists battery life of up to 14 days, so the exact plan should be confirmed.
SmartheartOS is a browser-based platform with no installation required. It covers examinations, patient data, reports, ordering, billing, and support, and allows users to choose between different AI models. The website states that the platform is hosted in Switzerland and complies with Swiss revDSG and GDPR. For collaboration, the materials emphasize support for cardiology practices, cross-department hospital use, family doctor networks, and clinical research. However, they do not disclose details on role-based permissions, audit logs, APIs, HL7/FHIR, or EHR integrations, so the maturity of its IT integration for large hospitals still requires further due diligence.
Pricing is not publicly disclosed. The site only states “no investment costs,” on-demand ordering, no commitments, and provides an entry point for a free test. Its advantages include a low barrier to getting started, outsourced device handling and logistics, improved detection probability for conditions such as paroxysmal atrial fibrillation through long-term monitoring, and local multilingual support in Switzerland. The drawbacks are limited pricing transparency, missing information on integrations and permissions, and the fact that Smartheart explicitly does not employ its own cardiologists, meaning final diagnosis remains the responsibility of the medical institution.
It is better suited to cardiology clinics, hospitals, family doctor networks, clinical research, and other departments requiring rhythm diagnostics in the Swiss and broader European context. Access from China is unknown. Its compliance, reimbursement, and service system are clearly centered on the Swiss market, so domestic institutions evaluating it should carefully confirm network availability, cross-border data compliance, payment methods, medical device approval, and local after-sales support. Alternatives include traditional Holter monitors, local hospital ambulatory ECG systems, and domestic long-term ECG patch services.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on mysmartheart.ch official site.
mysmartheart.ch is an Switzerland Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach mysmartheart.ch directly.